FHA
PRME icon

First Horizon Advisors’s Prime Medicine PRME Stock Holding History

First Horizon Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-932
Closed -$1.85K – 2464
2025
Q1 		$1.85K Sell
932
-177
-16% -$452 ﹤0.01% 2007
2024
Q4 		$3.24K Hold
1,109
– – ﹤0.01% 1904
2024
Q3 		$4.29K Sell
1,109
-25
-2% -$116 ﹤0.01% 1846
2024
Q2 		$5.83K Hold
1,134
– – ﹤0.01% 1716
2024
Q1 		$7.94K Buy
1,134
+324
+40% +$2.46K ﹤0.01% 1675
2023
Q4 		$7.18K Sell
810
-221
-21% -$1.7K ﹤0.01% 1698
2023
Q3 		$9.84K Sell
1,031
-524
-34% -$6.81K ﹤0.01% 1518
2023
Q2 		$22.8K Sell
1,555
-143
-8% -$2K ﹤0.01% 1216
2023
Q1 		$20.9K Sell
1,698
-115
-6% -$1.87K ﹤0.01% 1251
2022
Q4 		$33.7K Buy
+1,813
New +$32.7K ﹤0.01% 1040

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

First Horizon Advisors's PRME Position: Q2 2025 in Review

First Horizon Advisors sold out of Prime Medicine (PRME) in Q2 2025, closing a stake of 932 shares — an estimated $1.85K sold.

First Horizon Advisors first reported a position in PRME in Q4 2022 and held it in 10 quarters. The position peaked at $33.7K in Q4 2022. 121 funds tracked by Wall St. Rank hold PRME as of Q2 2025.

  • First Horizon Advisors reported no remaining Prime Medicine position as of Q2 2025 after selling out during the quarter.
  • First Horizon Advisors sold 932 Prime Medicine shares in Q2 2025, an estimated $1.85K.
  • First Horizon Advisors first reported a position in Prime Medicine in Q4 2022 and held it in 10 quarters.
  • First Horizon Advisors's Prime Medicine position peaked at $33.7K in Q4 2022.
  • 121 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.